<?xml version="1.0" encoding="UTF-8"?>
<p>PD 404, 182, primarily a bacterial KDO 8-P synthase inhibitor, has revealed the restraining of HCV pseudoparticles (HCVpp) and VSV-Gpp entry in a dose-dependent manner, which signifies the hindrance with a process entailed for the HCVpp entry [
 <xref ref-type="bibr" rid="B71">71</xref>]. Fluphenazine, PCperazine, and trifluoperazine were currently recognized as inhibitors of HCV entry [
 <xref ref-type="bibr" rid="B64">64</xref>]. These compounds alienated the D2 and D1 dopamine [
 <xref ref-type="bibr" rid="B65">65</xref>,
 <xref ref-type="bibr" rid="B66">66</xref>] and 5-HT2 serotonin receptors [
 <xref ref-type="bibr" rid="B67">67</xref>] in neural signaling networks.
</p>
